1. Home
  2. GRPN vs RAPP Comparison

GRPN vs RAPP Comparison

Compare GRPN & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRPN
  • RAPP
  • Stock Information
  • Founded
  • GRPN 2008
  • RAPP 2022
  • Country
  • GRPN United States
  • RAPP United States
  • Employees
  • GRPN N/A
  • RAPP N/A
  • Industry
  • GRPN Advertising
  • RAPP
  • Sector
  • GRPN Consumer Discretionary
  • RAPP
  • Exchange
  • GRPN Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • GRPN 534.1M
  • RAPP 513.5M
  • IPO Year
  • GRPN 2011
  • RAPP 2024
  • Fundamental
  • Price
  • GRPN $12.38
  • RAPP $12.68
  • Analyst Decision
  • GRPN Hold
  • RAPP Strong Buy
  • Analyst Count
  • GRPN 3
  • RAPP 4
  • Target Price
  • GRPN $17.00
  • RAPP $37.33
  • AVG Volume (30 Days)
  • GRPN 801.3K
  • RAPP 94.5K
  • Earning Date
  • GRPN 03-14-2025
  • RAPP 03-07-2025
  • Dividend Yield
  • GRPN N/A
  • RAPP N/A
  • EPS Growth
  • GRPN N/A
  • RAPP N/A
  • EPS
  • GRPN 0.52
  • RAPP N/A
  • Revenue
  • GRPN $499,894,000.00
  • RAPP N/A
  • Revenue This Year
  • GRPN N/A
  • RAPP N/A
  • Revenue Next Year
  • GRPN $0.32
  • RAPP N/A
  • P/E Ratio
  • GRPN $23.84
  • RAPP N/A
  • Revenue Growth
  • GRPN N/A
  • RAPP N/A
  • 52 Week Low
  • GRPN $7.75
  • RAPP $12.10
  • 52 Week High
  • GRPN $19.56
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • GRPN 56.40
  • RAPP N/A
  • Support Level
  • GRPN $11.30
  • RAPP N/A
  • Resistance Level
  • GRPN $13.82
  • RAPP N/A
  • Average True Range (ATR)
  • GRPN 0.66
  • RAPP 0.00
  • MACD
  • GRPN 0.16
  • RAPP 0.00
  • Stochastic Oscillator
  • GRPN 61.50
  • RAPP 0.00

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering a variety of products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: